NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Though I’d rather a long-term opportunity, I have generally been thinking along the same lines for a bit. The mandatory conversion was the first strong hint.

The recent SEC filing RE negotiations and the comp award, further bolstered my own strong suspicion that m&a transaction is very likely.

Additionally, a company in this situation without an m&a option would typically be discussing an active plan to re-list on a major exchange before release of topline data. There is no sign of such planning. To me, this is the biggest giveaway/tell.

Great post BSB!